Lorenza Borin

No ORCID on file · 2 papers in corpus · active 2022-2023

Study types

  • article 2

Condition tags

  • endometriosis 1
article 2023
Danazol Treatment for Thrombocytopenia in Myelodysplastic Syndromes: Can an “Old-fashioned” Drug be Effective?
·doi:10.1097/hs9.0000000000000867

Severe thrombocytopenia is a relatively uncommon event in myelodysplastic syndromes (MDS) and may occur in high-risk patients, advocating treatment with hypomethylating agents or with allogeneic bone marrow transplantation.1 In low-risk pat…

article 2022
Efficacy and Safety of Danazol in Patients with Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms: A Multicenter Observational Study
·doi:10.1182/blood-2022-157430

Thrombocytopenia affects about two thirds of patients with myelodysplastic syndromes (MDS) and treatment is not standardized. Immunosuppressants, such as corticosteroids, cyclosporin or anti-thymocyte globulin show some efficacy, particular…